8 Stock Market News for "CYBR"

Cybrexa Therapeutics’ Preclinical Data Demonstrate its alphalex™ Platform Enables Tumor Targeting of Multiple PARP Inhibitors, Effectively Inducing Significant Tumor Cell Killing When Combined with Chemotherapy

Results support the potential of alphalex™ technology with diverse range of anticancer agents Targets HRD-negative cancers, while avoiding significant bone marrow toxicity typically induced when PARP inhibitors are combined with chemotherapy NEW HAVEN, Conn., May 15, 2019 (GLOBE NEWSWIRE) — Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through it... »

Evolve Announces May 2019 Distributions for Evolve ETFs

TORONTO, May 24, 2019 /CNW/ – Evolve Funds Group Inc. (“Evolve”) is pleased to announce the distribution amounts per unit (the “Distributions”) for certain exchange traded funds (the “Evolve ETFs”) for the period ending May 31, 2019, as indicated in the table below. Unitholders of record on May 31, 2019 will receive cash distributions payable on or about J... »

MWA DEADLINE REMINDER: Rosen Law Firm Reminds Mueller Water Products, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors With Over $100K in Losses to Contact the Firm – MWA

NEW YORK, May 19, 2019 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminders purchasers of the securities of Mueller Water Products, Inc. (NYSE: MWA) from May 9, 2016 through August 6, 2018, inclusive (the “Class Period”) of the important June 10, 2019 lead plaintiff deadline in class action. The lawsuit seeks to recover damages for Mueller investors under the feder... »

Guardant Health to Present Precision Oncology Data Across the Continuum of Care at the ASCO Annual Meeting

REDWOOD CITY, Calif., May 15, 2019 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH), along with researchers from leading academic institutions and pharmaceutical companies, will present 27 abstracts at the ASCO Annual Meeting detailing new insights into precision oncology generated from its commercially available Guardant360 and GuardantOMNI assays, as well as its research-use-only (RUO... »

3 Cyberark Bulls Share Takeaways From Q1 Print

IT security company Cyberark Software Ltd (NASDAQ: CYBR) reported first-quarter results Tuesday that arrived better than expected and prompted several Street analysts to turn incrementally bullish on the stock. The Analysts Wedbush’s Daniel Ives maintained an Outperform rating on Cyberark with a price target lifted from $140 to $145. Mizuho Securities’ Gregg Moskowitz&nb... »

SpinalCyte Launches Initiative to Highlight Advances in Fibroblast Technology

HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a clinical stage regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced a new comprehensive resource to raise awareness of the potential benefits of fibroblasts and provide a growing knowledge base for this promising regenerative medicine technology. The company’s website, www.... »

Bragar Eagel & Squire, P.C. is Investigating Ra Medical Systems, Inc. (NYSE: RMED) on Behalf of Ra Medical Stockholders and Encourages Ra Medical Investors to Contact the Firm

NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C. is investigating potential claims against Ra Medical Systems, Inc. (NYSE:RMED) on behalf of Ra Medical stockholders.  Our investigation concerns whether Ra Medical has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. In September 201... »

Rigrodsky & Long, P.A. Files Class Action Suit Against Worldpay, Inc.

WILMINGTON, Del., May 04, 2019 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A.: Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Worldpay, Inc. (“Worldpay”) (NYSE: WP) common stock in connection with the proposed acquisition of Worldpay by Fidelity National Information Servic... »